|
2OK9
PrTX-I-BPB
Deposited 2007-01-16
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–121(121 aa)
Chain B
1–121(121 aa)
|
Not recorded
|
PBP p-Bromophenacyl bromide × 2
IPA ISOPROPYL ALCOHOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;291 K;23% PEG 4000, 20% 2-propanol, 0.1M sodium citrate, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.34 Å
R-free 0.252
|
|
3QNL
Crystal structure of PrTX-I complexed to Rosmarinic Acid
Deposited 2011-02-08
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–121(121 aa)
Chain B
1–121(121 aa)
|
Not recorded
|
IPA ISOPROPYL ALCOHOL × 8
ROA (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid × 1
P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;20% PEG 4000, sodium citrate pH 5.6, 20% 2-propanol, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 1.77 Å
R-free 0.218
|
|
4YU7
Crystal structure of Piratoxin I (PrTX-I) complexed to caffeic acid
Deposited 2015-03-18
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–121(121 aa)
Chain B
1–121(121 aa)
|
Not recorded
|
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 3
DHC CAFFEIC ACID × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.1;291 K;PEG4000, Tris HCl pH 8.1, lithium sulfate.
|
Resolution 1.65 Å
R-free 0.229
|
|
4YZ7
Crystal structure of Piratoxin I (PrTX-I) complexed to aristolochic acid
Deposited 2015-03-24
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–121(121 aa)
Chain B
1–121(121 aa)
|
Not recorded
|
SO4 SULFATE ION × 5
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
9AR 9-HYDROXY ARISTOLOCHIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.1;291 K;PEG 4000, Tris HCl pH 8.1 and lithium sulfate
|
Resolution 1.96 Å
R-free 0.235
|
|
8DND
Crystal structure of Bothrops pirajai Piratoxin-I (PrTX-I) and synthetic inhibitor Varespladib (LY315920)
Deposited 2022-07-11
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–121(121 aa)
Chain B
1–121(121 aa)
|
Not recorded
|
VRD ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid × 3
SO4 SULFATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;30% w/v PEG 4000, 0.1 M Tris HCl pH 8.5 and 0.2 M lithium sulfate
|
Resolution 2.02 Å
R-free 0.217
|
|
9Z5Y
Crystal structure of Bothrops pirajai myotoxin I PrTX-I complexed with inhibitor AZD2716
Deposited 2025-11-13
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–121(121 aa)
Chain B
1–121(121 aa)
|
Not recorded
|
A1C06 (2R)-3-[(1M)-5'-benzyl-2'-carbamoyl[1,1'-biphenyl]-3-yl]-2-methylpropanoic acid × 2
SO4 SULFATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;293 K;PEG 4000, Tris HCl, Lithium Sulfate
|
Resolution 2.75 Å
R-free 0.269
|